These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1013790)

  • 41. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immune mechanisms in chronic liver diseases].
    Fodor O; Părău N; Urcan S; Dejica D; Fodor I
    Med Interne; 1975; 13(4):283-9. PubMed ID: 1243198
    [No Abstract]   [Full Text] [Related]  

  • 43. [Evolution of humoral immunity in acute and chronic diffuse hepatopathies and its role in the differential diagnosis between HBAg-positive and HBAg-negative patients].
    Sánchez-Cuenca JM; Rodrigo-Moreno M; González-Molina A; Sarrión-Martínez JV; Rayon M; Beneyto M; Baguena J; Berenguer J
    Rev Clin Esp; 1976 Mar; 140(6):557-66. PubMed ID: 1273358
    [No Abstract]   [Full Text] [Related]  

  • 44. Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.
    Hadziyannis S; Gerber MA; Vissoulis C; Popper H
    Arch Pathol; 1973 Nov; 96(5):327-30. PubMed ID: 4582440
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis-associated, antigen-induced lymphocyte transformation in chronic hepatic disease.
    Pettigrew N; Russell RI
    Gut; 1972 Oct; 13(10):852-3. PubMed ID: 5087114
    [No Abstract]   [Full Text] [Related]  

  • 46. Hepatic histology in chronic liver disease in hepatitis B surface antigen positive cases.
    Ghosh AK; Dasgupta A; Raha K; Jana A; Majumdar DN
    J Indian Med Assoc; 1994 Oct; 92(10):333-5. PubMed ID: 7822848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histologic observation of hepatitis B antigen ("Shikata cells") in diseases of the liver.
    Medline A; Shin DH; Medline NM; Adams RE
    Indian J Pathol Microbiol; 1976 Jan; 19(1):15-21. PubMed ID: 977050
    [No Abstract]   [Full Text] [Related]  

  • 49. Morphological markers with predictive-evolutive value in liver diseases.
    Banciu T; Tudose N
    Med Interne; 1984; 22(4):297-301. PubMed ID: 6515294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Distribution of subtype (D and Y) in Australia-antigen (AuAg)-positive hepatopathies].
    Kindler U; Schoppe WD; Arnold HG
    Med Welt; 1975 Sep; 26(37):1635-7. PubMed ID: 1177725
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum HBV-DNA in delta antigen positive chronic liver disease.
    Hadziyannis SJ; Shafritz DA
    Dev Biol Stand; 1985; 59():141-5. PubMed ID: 3891460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quantitative immunoelectrophoresis as a method for determination of hepatitis B antigen. Standardization and comparison with other methods (author's transl)].
    Yano M; Tripatzis I
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):174-86. PubMed ID: 4143165
    [No Abstract]   [Full Text] [Related]  

  • 54. High titres of antibodies against rubella and morbilli virus in patients with chronic hepatitis.
    Closs O; Haukenes G; Blomhoff JP; Gjone E
    Scand J Gastroenterol; 1973; 8(6):523-8. PubMed ID: 4129583
    [No Abstract]   [Full Text] [Related]  

  • 55. [Viral antigens in liver tissue].
    Callea F; Baronchelli C; Guerini A; Rodolfi A; Bercich L
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):51-4. PubMed ID: 7619965
    [No Abstract]   [Full Text] [Related]  

  • 56. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The incidence of hepatitis B antigen subtypes in acute hepatitis and chronic liver diseases].
    Büki B; Szalay F; Nagylucskay S; Schvaáb E
    Orv Hetil; 1975 Jul; 116(27):1567-9. PubMed ID: 1143846
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlation between Australia (HB Au) antigen and the humoral immunological aspects in liver diseases].
    García Cabezas J; García Molinero MJ; Yuguero del Moral L; Garralón Velasco RM; Fernández-Cruz A
    Rev Clin Esp; 1976 Sep; 142(5):419-25. PubMed ID: 968130
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidence of Australia antigen-antibody in acute and chronic liver disease.
    Purves LR
    S Afr Med J; 1971 Dec; 45(46):1348. PubMed ID: 5135697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.